Published in BMC Mol Biol on August 24, 2001
Termination of translation: interplay of mRNA, rRNAs and release factors? EMBO J (2003) 2.20
Following Ariadne's thread: a new perspective on RBR ubiquitin ligases. BMC Biol (2012) 1.33
The major 5' determinant in stop codon read-through involves two adjacent adenines. Nucleic Acids Res (2004) 1.11
N-terminal region of Saccharomyces cerevisiae eRF3 is essential for the functioning of the eRF1/eRF3 complex beyond translation termination. BMC Mol Biol (2006) 1.04
GTP-dependent structural rearrangement of the eRF1:eRF3 complex and eRF3 sequence motifs essential for PABP binding. Nucleic Acids Res (2009) 0.90
Fine-tuning of translation termination efficiency in Saccharomyces cerevisiae involves two factors in close proximity to the exit tunnel of the ribosome. Genetics (2007) 0.89
Cosuppression of eukaryotic release factor 1-1 in Arabidopsis affects cell elongation and radial cell division. Plant Physiol (2005) 0.86
Mutation at tyrosine in AMLRY (GILRY like) motif of yeast eRF1 on nonsense codons suppression and binding affinity to eRF3. Int J Biol Sci (2008) 0.82
Mutants of the Paf1 complex alter phenotypic expression of the yeast prion [PSI+]. Mol Biol Cell (2009) 0.80
Eukaryotic release factor 1-2 affects Arabidopsis responses to glucose and phytohormones during germination and early seedling development. J Exp Bot (2009) 0.80
A genetic approach for analyzing the co-operative function of the tRNA mimicry complex, eRF1/eRF3, in translation termination on the ribosome. Nucleic Acids Res (2014) 0.78
Elongation factor eEF1B modulates functions of the release factors eRF1 and eRF3 and the efficiency of translation termination in yeast. BMC Mol Biol (2009) 0.78
Modulation of efficiency of translation termination in Saccharomyces cerevisiae. Prion (2014) 0.76
In Aspergillus nidulans the suppressors suaA and suaC code for release factors eRF1 and eRF3 and suaD codes for a glutamine tRNA. G3 (Bethesda) (2014) 0.76
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene (1988) 52.71
A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature (2000) 47.15
New yeast-Escherichia coli shuttle vectors constructed with in vitro mutagenized yeast genes lacking six-base pair restriction sites. Gene (1988) 42.65
Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure. Yeast (1995) 13.20
RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc Natl Acad Sci U S A (1999) 7.32
Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells. Annu Rev Biochem (1996) 7.08
Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J (1996) 5.50
A sampling of the yeast proteome. Mol Cell Biol (1999) 5.12
Yeast Saccharomyces cerevisiae selectable markers in pUC18 polylinkers. Yeast (1990) 5.00
Does this have a familiar RING? Trends Biochem Sci (1996) 4.80
The products of the SUP45 (eRF1) and SUP35 genes interact to mediate translation termination in Saccharomyces cerevisiae. EMBO J (1995) 4.68
Termination of translation in eukaryotes is governed by two interacting polypeptide chain release factors, eRF1 and eRF3. EMBO J (1995) 4.66
A highly conserved eukaryotic protein family possessing properties of polypeptide chain release factor. Nature (1994) 4.21
The SUP35 omnipotent suppressor gene is involved in the maintenance of the non-Mendelian determinant [psi+] in the yeast Saccharomyces cerevisiae. Genetics (1994) 4.04
Deletion analysis of the SUP35 gene of the yeast Saccharomyces cerevisiae reveals two non-overlapping functional regions in the encoded protein. Mol Microbiol (1993) 3.76
The surveillance complex interacts with the translation release factors to enhance termination and degrade aberrant mRNAs. Genes Dev (1998) 3.71
Genetic and biochemical characterization of mutations in the ATPase and helicase regions of the Upf1 protein. Mol Cell Biol (1996) 2.78
Eukaryotic polypeptide chain release factor eRF3 is an eRF1- and ribosome-dependent guanosine triphosphatase. RNA (1996) 2.48
Yeast Upf proteins required for RNA surveillance affect global expression of the yeast transcriptome. Mol Cell Biol (1999) 2.37
Identification and characterization of mutations in the UPF1 gene that affect nonsense suppression and the formation of the Upf protein complex but not mRNA turnover. Mol Cell Biol (1996) 2.35
Nucleotide sequence of the SUP2 (SUP35) gene of Saccharomyces cerevisiae. Gene (1988) 2.12
Upf1p control of nonsense mRNA translation is regulated by Nmd2p and Upf3p. Mol Cell Biol (2000) 1.70
Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor. J Biol Chem (1999) 1.69
Interaction between yeast Sup45p (eRF1) and Sup35p (eRF3) polypeptide chain release factors: implications for prion-dependent regulation. Mol Cell Biol (1997) 1.61
The stretch of C-terminal acidic amino acids of translational release factor eRF1 is a primary binding site for eRF3 of fission yeast. RNA (1998) 1.54
Interaction of the yeast omnipotent suppressors SUP1(SUP45) and SUP2(SUP35) with non-mendelian factors. Genetics (1991) 1.52
Functional expression of eukaryotic polypeptide chain release factors 1 and 3 by means of baculovirus/insect cells and complex formation between the factors. Eur J Biochem (1998) 1.45
A mutant allele of the SUP45 (SAL4) gene of Saccharomyces cerevisiae shows temperature-dependent allosuppressor and omnipotent suppressor phenotypes. Curr Genet (1995) 1.40
Overexpression of human release factor 1 alone has an antisuppressor effect in human cells. Mol Cell Biol (1997) 1.30
The use of proline as a nitrogen source causes hypersensitivity to, and allows more economical use of 5FOA in Saccharomyces cerevisiae. Yeast (1992) 1.27
TRIADs: a new class of proteins with a novel cysteine-rich signature. Protein Sci (1999) 1.16
Transcriptional activity of RBCK1 protein (RBCC protein interacting with PKC 1): requirement of RING-finger and B-Box motifs and regulation by protein kinases. Biochem Biophys Res Commun (1998) 0.92
Yeast DNA helicase A: cloning, expression, purification, and enzymatic characterization. Biochemistry (1997) 0.86
Biochemical and genetic characterization of a replication protein A dependent DNA helicase from the yeast, Saccharomyces cerevisiae. Biochem Biophys Res Commun (1995) 0.82
Purification and characterization of DNA polymerase alpha-associated replication protein A-dependent yeast DNA helicase A. Biochemistry (1997) 0.81
Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J (1996) 5.50
Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae. Genetics (1996) 5.19
The products of the SUP45 (eRF1) and SUP35 genes interact to mediate translation termination in Saccharomyces cerevisiae. EMBO J (1995) 4.68
The SUP35 omnipotent suppressor gene is involved in the maintenance of the non-Mendelian determinant [psi+] in the yeast Saccharomyces cerevisiae. Genetics (1994) 4.04
Deletion analysis of the SUP35 gene of the yeast Saccharomyces cerevisiae reveals two non-overlapping functional regions in the encoded protein. Mol Microbiol (1993) 3.76
The surveillance complex interacts with the translation release factors to enhance termination and degrade aberrant mRNAs. Genes Dev (1998) 3.71
In vitro propagation of the prion-like state of yeast Sup35 protein. Science (1997) 3.05
Nucleotide sequence of the SUP2 (SUP35) gene of Saccharomyces cerevisiae. Gene (1988) 2.12
Isolation and characterization of actin-like protein from yeast Saccharomyces cerevisiae. FEBS Lett (1979) 2.06
Chaperones that cure yeast artificial [PSI+] and their prion-specific effects. Curr Biol (2000) 1.96
Prion properties of the Sup35 protein of yeast Pichia methanolica. EMBO J (2000) 1.94
Structure and replication of yeast prions. Cell (1998) 1.91
Divergence and conservation of SUP2 (SUP35) gene of yeast Pichia pinus and Saccharomyces cerevisiae. Yeast (1991) 1.72
Red pigment of adenine-deficient yeast Saccharomyces cerevisiae. Biochem Biophys Res Commun (1967) 1.67
Interaction between yeast Sup45p (eRF1) and Sup35p (eRF3) polypeptide chain release factors: implications for prion-dependent regulation. Mol Cell Biol (1997) 1.61
Interaction of the yeast omnipotent suppressors SUP1(SUP45) and SUP2(SUP35) with non-mendelian factors. Genetics (1991) 1.52
Ribosome-bound EF-1 alpha-like protein of yeast Saccharomyces cerevisiae. Eur J Biochem (1991) 1.49
Modulation of human aorta smooth muscle cell phenotype: a study of muscle-specific variants of vinculin, caldesmon, and actin expression. Proc Natl Acad Sci U S A (1988) 1.38
Dosage-dependent translational suppression in yeast Saccharomyces cerevisiae. Yeast (1992) 1.35
Mechano-chemical control of human endothelium orientation and size. J Cell Biol (1989) 1.33
Mechanism of inhibition of Psi+ prion determinant propagation by a mutation of the N-terminus of the yeast Sup35 protein. EMBO J (1998) 1.31
Recessive suppression in yeast Saccharomyces cerevisiae is mediated by a ribosomal mutation. FEBS Lett (1980) 1.30
Recessive super-suppression in yeast. Mol Gen Genet (1974) 1.29
Studies of energy transport in heart cells. Mitochondrial isoenzyme of creatine phosphokinase: kinetic properties and regulatory action of Mg2+ ions. Eur J Biochem (1975) 1.28
C-terminal truncation of the Sup35 protein increases the frequency of de novo generation of a prion-based [PSI+] determinant in Saccharomyces cerevisiae. Curr Genet (1998) 1.26
Recessive nonsense-suppression in yeast: further characterization of a defect in translation. FEBS Lett (1976) 1.24
Stretch affects phenotype and proliferation of vascular smooth muscle cells. Mol Cell Biochem (1995) 1.21
Morphological alterations in endothelial cells from human aorta and umbilical vein induced by forskolin and phorbol 12-myristate 13-acetate: a synergistic action of adenylate cyclase and protein kinase C activators. Proc Natl Acad Sci U S A (1986) 1.17
[Psi(+)] prion generation in yeast: characterization of the 'strain' difference. Yeast (2001) 1.15
Role of creatine phosphokinase in cellular function and metabolism. Can J Physiol Pharmacol (1978) 1.09
Primary culture of endothelial cells from atherosclerotic human aorta. Part 1. Identification, morphological and ultrastructural characteristics of two endothelial cell subpopulations. Atherosclerosis (1986) 1.04
Plasmid reorganization during integrative transformation in Hansenula polymorpha. Yeast (1995) 1.03
Studies of energy transport in heart cells. The functional coupling between mitochondrial creatine phosphokinase and ATP ADP translocase: kinetic evidence. Arch Biochem Biophys (1976) 1.02
A study of the structure of fibronectin. Eur J Biochem (1981) 1.00
Calcium-binding rate and capacity of cardiac sarcoplasmic reticulum. J Mol Cell Cardiol (1981) 1.00
Cell proliferation in normal and atherosclerotic human aorta. I. Flow cytofluorometric determination of cellular deoxyribonucleic acid content. Lab Invest (1983) 1.00
Regulation of energy flux through the creatine kinase reaction in vitro and in perfused rat heart. 31P-NMR studies. Biochim Biophys Acta (1984) 1.00
A conditional-lethal translation termination defect in a sup45 mutant of the yeast Saccharomyces cerevisiae. Eur J Biochem (1997) 0.97
Endothelial cell culture on fibrillar collagen: model to study platelet adhesion and liposome targeting to intercellular collagen matrix. Proc Natl Acad Sci U S A (1981) 0.96
Heterogeneity of endothelium in human aorta. A quantitative analysis by scanning electron microscopy. Atherosclerosis (1984) 0.96
Recessive nonsense-suppression in yeast: involvement of 60S ribosomal subunit. Mol Gen Genet (1978) 0.95
Ribosomal recessive suppressors cause a respiratory deficiency in yeast Saccharomyces cerevisiae. Mol Gen Genet (1982) 0.94
Kinetic properties and the functional role of particulate MM-isoenzyme of creatine phosphokinase bound to heart muscle myofibrils. FEBS Lett (1976) 0.94
Cellular composition of atherosclerotic and uninvolved human aortic subendothelial intima. Light-microscopic study of dissociated aortic cells. Am J Pathol (1984) 0.94
Isolation and characterization of the LEU2 gene of Hansenula polymorpha. Yeast (1994) 0.93
Cytomegalovirus genome and the immediate-early antigen in cells of different layers of human aorta. Virchows Arch (2000) 0.92
Evidence of antiatherosclerotic action of verapamil from direct effects on arterial cells. Am J Cardiol (1987) 0.92
Centrosome injury in cells infected with human cytomegalovirus. J Struct Biol (1997) 0.91
Preservation of antimyosin antibody activity after covalent coupling to liposomes. Biochem Biophys Res Commun (1979) 0.91
Mutation of the homologue of GDP-mannose pyrophosphorylase alters cell wall structure, protein glycosylation and secretion in Hansenula polymorpha. Yeast (2001) 0.91
Study of energy transport mechanism in myocardial cells. Circ Res (1974) 0.90
Cell proliferation in normal and atherosclerotic human aorta. II. Autoradiographic observation on deoxyribonucleic acid synthesis in primary cell culture. Lab Invest (1983) 0.90
A dominant selection system designed for copy-number-controlled gene integration in Hansenula polymorpha DL-1. Appl Microbiol Biotechnol (1999) 0.90
Ssb1 chaperone is a [PSI+] prion-curing factor. Curr Genet (2001) 0.90
Immunotargeting of erythrocyte-bound streptokinase provides local lysis of a fibrin clot. Biochim Biophys Acta (1986) 0.88
Prions. Biochemistry (Mosc) (2007) 0.87
[Structure and functional similarity of yeast Sup35p and Ure2p proteins to mammalian prions]. Mol Biol (Mosk) (1995) 0.87
Immunoreactive forms of caldesmon in cultivated human vascular smooth muscle cells. FEBS Lett (1987) 0.87
The effect of primary products of lipid peroxidation on the transmembrane transport of calcium ions. J Mol Cell Cardiol (1982) 0.86
Primary culture of human aortic intima cells as a model for testing antiatherosclerotic drugs. Effects of cyclic AMP, prostaglandins, calcium antagonists, antioxidants, and lipid-lowering agents. Atherosclerosis (1986) 0.86
Taurine and electrical activity of the heart. Circ Res (1974) 0.86
Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation. Circ Res (1992) 0.86
A novel autonomously replicating sequence (ARS) for multiple integration in the yeast Hansenula polymorpha DL-1. J Bacteriol (1996) 0.86
Translation termination factors function outside of translation: yeast eRF1 interacts with myosin light chain, Mlc1p, to effect cytokinesis. Mol Microbiol (2004) 0.86
Carrier-directed targeting of liposomes and erythrocytes to denuded areas of vessel wall. Proc Natl Acad Sci U S A (1986) 0.86
Trapidil derivatives as potential antiatherosclerotic drugs. Arzneimittelforschung (1987) 0.86
Red blood cell targeting to collagen-coated surfaces. FEBS Lett (1983) 0.85
Localization of possible functional domains in sup2 gene product of the yeast Saccharomyces cerevisiae. FEBS Lett (1987) 0.85
Further characterization of recessive suppression in yeast. Isolation of the low-temperature sensitive mutant of Saccharomyces cerevisiae defective in the assembly of 60 S ribosomal subunit. Biochim Biophys Acta (1981) 0.85
On the mechanism of enhanced ATP formation in hypoxic myocardium caused by glutamic acid. Basic Res Cardiol (1985) 0.85
Autoantibodies against modified low density lipoprotein. Nonlipid factor of blood plasma that stimulates foam cell formation. Arterioscler Thromb (1991) 0.85
Electron microscopy study of fibronectin structure. FEBS Lett (1980) 0.85